alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.0**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report on Form 10-Qof Fox Chase Bancorp, Inc. (the “Company”) on Form 10-Q for the quarterlyperiod ended March 31, 2009, as filed with the Securities and ExchangeCommission (the “Report”), I hereby certify, pursuant to 18 U.S.C. Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,that:

 

1.                        The Report fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934, as amended; and

 

2.                        The information contained in the Reportfairly presents, in all material respects, the consolidated financial conditionand results of operations of the Company as of and for the period covered bythe Report.

 
|   | By:    | /s/ Thomas M.  Petro                   |
|--------|--------|----------------------------------------|
|   |   | Thomas  M. Petro                       |
|   |   | President  and Chief Executive Officer |
|   |   | May 8,  2009                      |
|   |   |                                   |
|   | By:    | /s/ Roger S.  Deacon                   |
|   |   | Roger  S. Deacon                       |
|   |   | Chief  Financial Officer               |
|   |   | May 8,  2009                      |

 

----
[Federal Register Volume 74, Number 123 (Monday, June 29, 2009)]
[Notices]
[Page 31054]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15285]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-65,795]


Caye Upholstery, Amory, MS; Notice of Termination of 
Investigation

    Pursuant to Section 221 of the Trade Act of 1974, as amended, an 
investigation was initiated on April 15, 2009 in response to a worker 
petition filed by workers of Caye Upholstery, Amory, Mississippi.
    The petitioners have requested that the petition be withdrawn. 
Consequently, the investigation has been terminated.

    Signed at Washington, DC, this 19th day of May 2009.
Elliott S. Kushner,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E9-15285 Filed 6-26-09; 8:45 am]
BILLING CODE 4510-FN-P
**Exhibit
      32.2**




CERTIFICATION
      PURSUANT TO




18
      U.S.C.
      SECTION 1350,




AS
      ADOPTED PURSUANT TO




SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002




In
      connection with the quarterly report of ES Bancshares, Inc. (the “Company”) on
      Form 10-QSB for the period ending September 30, 2006 as filed with the Office
      of
      the Comptroller of the Currency on the date hereof (the “Report”), I, Arthur W.
      Budich, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
      Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
      of
      2002, that:




(1)
            The
                report fully complies with the requirements of Section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934;
                and




(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.




Date: November
              14, 2006
            /s/
                Arthur W. Budich
              Arthur
                W. Budich
              Chief
                Financial
                Officer
cc: Hon. Kathleen E. Delaney, District Judge 

Diana M. Turner 

Ronald M. Turner 

Wright, Finlay & Zak, LLP/Las Vegas 

Eighth District Court Clerk 

SUPREME COURT 

OF 

NEVADA 2 

(0) 1947A e
IN THE SUPREME COURT OF PENNSYLVANIA WESTERN DISTRICT IN THE INTEREST OF: S.A.S., JR. PETITION OF: S.S., SR., NATURAL FATHER : : : : : No. 259 WAL 2015 Petition for Allowance of Appeal from the Order of the Superior Court ORDER PER CURIAM AND NOW , this 26th day of August, 2015, the Petition for Allowance of Appeal is DENIED

.
|Description of Short-term Compensation Plan | Exhibit 10.12
|------------------------------------------- | -------------

As
part of the total compensation package for the nine top executive officers who are members
of the Companys Senior Leadership Team and other executives (the
Executives), the Management Continuity and Compensation Committee
(MCC) of the Board of Directors sets annual earnings per share
(EPS) targets for the Company. The MCC then grants contingent award values to
the Executives pursuant to the Bandag, Incorporated Stock Award Plan. The award values are
typically based on a percentage of the target compensations for the Executives set by the
MCC. The awards are payable in restricted shares of Class A Common Stock if the EPS
targets are met.

The
MCC sets the EPS targets and award values to the Executives as follows: the first is a
Threshold EPS, below which no restricted stock grants are made and, if met, provides for
the lowest award value; the second is a Target EPS, which provides for a higher award
value if the Target EPS is met; and the third is a superior EPS, which provides for the
highest award value if the Superior EPS is met. If EPS falls between identified target EPS
numbers, arithmetical interpolation is used to determine the award value. The number of
shares of restricted stock to be granted are computed by dividing an individual award
value by the fair market value of a share of Class A Common Stock on the fourth Tuesday in February
following the public release of annual financial results of the
Company. The shares of restricted stock become freely transferable after three years from
the date of grant, but terminate if employment is terminated within such three-year
period, except that the shares vest and become freely transferable if the termination of
employment is caused by death, Disability or Retirement, as Disability and Retirement are
defined in the Stock Award Plan.

The
executive officers receiving the contingent awards currently are:

|Martin G. Carver      | Chairman of the Board, President and Chief Executive Officer    
|--------------------- | ----------------------------------------------------------------
|Warren W. Heidbreder  | Vice President, Chief Financial Office and Secretary            
|John C. McErlane      | Vice President of the Company and President of Tire Distribution
|                      | Systems, Inc., a wholly owned subsidiary of the Company         
|Nathaniel L. Derby II | Vice President, Manufacturing Design                            
|Frederico V. Kopittke | Vice President, International                                   
|Michael A. Tirona     | Vice President and General Manager - Europe                     
|Janet R. Sichterman   | Vice President, NorthAmerican Fleet Sales                       
|Andrew M. Sisler      | Vice President, North American Franchise Sales                  
|Timothy Chen          | Vice President, Innovation
EXHIBIT
32.1





CERTIFICATION
OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER


PURSUANT
TO 18 U.S.C. SECTION 1350 (SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002)





In
connection with the Annual Report of MultiCell Technologies, Inc. (the
“Company”) on Form 10-KSB/A for the fiscal year ended November 30, 2008, as
filed with the Securities and Exchange Commission on the date hereof (the
“Report”), I, W. Gerald Newmin, Chief Executive Officer and Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:





1.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934;
and





2.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.








Dated:
      August 7, 2009By:
            /s/
      W. Gerald NewminName:
            W.
      Gerald NewminChief
      Executive Officer and Chief Financial
Officer
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 15-0141V

Filed: June 16, 2015

Unpublished

* * * * * * * * * * * * * * * * * * * * * * * * * * * *

BRIDGETTE WILEY, *

*

Petitioner, * Ruling on Entitlement; Concession;

v. * Influenza or Flu Vaccine; Shoulder

* Injury Related to Vaccine Administration

SECRETARY OF HEALTH * (“SIRVA”); Special Processing Unit

AND HUMAN SERVICES, * (“SPU”)

*

Respondent. *

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * *

Jeffrey S. Pop, Esq., Jeffrey S. Pop, Attorney at Law, Beverly Hills, CA, for petitioner.

Christine M. Becer, Esq., U.S. Department of Justice, Washington, DC for respondent.

RULING ON ENTITLEMENT1

Vowell, Chief Special Master:

On February 11, 2015, Bridgette Wiley filed a petition for compensation under the 

National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,

2

[the 

“Vaccine Act” or “Program”]. Petitioner alleges that she suffered an adverse reaction to 

the influenza vaccine she received on November 21, 2012 resulting in severe pain and 

several surgeries. Petition, ¶¶ 4, 39. The case was assigned to the Special Processing 

Unit of the Office of Special Masters.

On June 15, 2015, respondent filed her Rule 4(c) report in which she 

“recommends that compensation be awarded in this case.” Respondent’s Rule 4(c) 

Report at 1. Specifically, respondent “has concluded that a preponderance of evidence 

establishes that the injury to petitioner’s right shoulder was caused-in-fact by the 

administration of her November 21, 2012, flu vaccine, and that petitioner’s injury is not 

 

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I intend to 

post it on the United States Court of Federal Claims' website, in accordance with the E-Government Act 

of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 

note (2006)). In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to 

redact medical or other information, the disclosure of which would constitute an unwarranted invasion of

privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such 

material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for 

ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 

300aa (2006).
2

due to factors unrelated to the administration of the flu vaccine.” Id. at 3-4.

Furthermore, respondent agrees that petitioner’s injury lasted for more than six months. 

Id. at 4.

In view of respondent’s concession and the evidence before me, I find that 

petitioner is entitled to compensation.

s/Denise K. Vowell

Denise K. Vowell

Chief Special Master
```

[Federal Register Volume 74, Number 120 (Wednesday, June 24, 2009)]
[Notices]
[Pages 30100-30101]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14898]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

U.S. Customs and Border Protection

Accreditation and Approval of SGS North America, Inc., as a 
Commercial Gauger and Laboratory

AGENCY: U.S. Customs and Border Protection, Department of Homeland 
Security.

ACTION: Notice of accreditation and approval of SGS North America, 
Inc., as a commercial gauger and laboratory.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that, pursuant to 19 CFR 151.12 and 19 
CFR 151.13, SGS North America, Inc., 4701 East Napoleon (Hwy 90), 
Sulfur, LA 70663, has been approved to gauge and accredited to test 
petroleum and petroleum products, organic chemicals and vegetable oils 
for customs purposes, in accordance with the provisions of 19 CFR 
151.12 and 19 CFR 151.13. Anyone wishing to employ this entity to 
conduct laboratory analyses and gauger services should request and 
receive written assurances from the entity that it is accredited or 
approved by the U.S. Customs and Border Protection to conduct the 
specific test or gauger service requested. Alternatively, inquires 
regarding the specific test or gauger service this entity is accredited 
or approved to perform may be directed to the U.S. Customs and Border 
Protection by calling (202) 344-1060. The inquiry may also be sent to

[[Page 30101]]

[email protected]. Please reference the Web site listed below for a 
complete listing of CBP approved gaugers and accredited laboratories. 
http://cbp.gov/xp/cgov/import/operations_support/labs_scientific_svcs/commercial_gaugers/.

DATES: The accreditation and approval of SGS North America, Inc., as 
commercial gauger and laboratory became effective on April 8, 2009. The 
next triennial inspection date will be scheduled for April 2012.

FOR FURTHER INFORMATION CONTACT: Anthony Malana, Laboratories and 
Scientific Services, U.S. Customs and Border Protection, 1300 
Pennsylvania Avenue, NW., Suite 1500N, Washington, DC 20229, 202-344-
1060.

    Dated: June 18, 2009.
Ira S. Reese,
Executive Director, Laboratories and Scientific Services.
[FR Doc. E9-14898 Filed 6-23-09; 8:45 am]
BILLING CODE 9111-14-P
```
Qu, Uasor

Tuly 14,2015 RECEIVED IN

: —— COURT OF CRIMINAL APPEALS
eas Couct oF Coiminal &
Ben, Budge Biane Rens “ae
RO. BOK 12308
Abel Acosta, Glark

Wuoshkia, WAS WV
Deac Budge WEnson /

You stared thar "a yudge should ond
Aa o\- aA ses aw and do he we Nate on
en You owe Kchae\ Moth
eridence Ynad \ed Yo is Chonecation re NA teat the
ANE AUWSHiM Voice Begacs + andthe WavisS
Cound) d9's.06Fice POre WWiteen wee of yhe
Pecson Whe Killed mj ausband. Bul Yel refuse to
HONE ATEN dents €reds woe Rowess ANd Sot Yolancorwld
WAL NO SLY : .
AS SAAN EO : Ys COULA TOS He dened

Fae yacy dre ‘AMES SNges QvNts ©:
HecOVse WO OWS A AHS BASIN PO CE yegareergre
COMA USE WME VASES FANGS PAM MACHINE Ade FS aby

Budge 9: = ve
Rick Corso) ALO TO Tedoai Cran
WAN ENOONSS Vases Reagent Tpackhwne. Was 10
Anse OF AWE Heme OF MY WASHORAS WMUPAEe! | 25
s Sane > een Osh ‘ages N Ny amdshe v & AO a
en Wore \
Aa teh ASRS Naenkoee Ze FRI have

\ wn \o . ex 0 .

ON SN Wise Wik WOMAN Eager Pci nts
\o \+ fy .
‘nok is Mae Relic e And YOOSECULOCS EACU SE pow

Ry AL WENSID) WIWYOw Please ISSAE ON Be ecto ,
Wee WHSA BOREL Regdceeens and “Teavis County PAS

vce vo Nave VE Leicregn IMALGREUNTS OF the Ger-
Som Wd Killed wy Husband \ACAE TS 2d\ Soucan be Te-
eased Seam Wis Arnlawm Sul Convichisn T

“ Resgeck Cully TeQnested:

Siacecely,
apm cosy Werte

“Noome as\ty Moot
Muccay Unit Se CSE
NOVG Ns Hin 3b BYPASS,
LaabesN Me) Teas. 76596
EXHIBIT 31(b)



I, Bruce W. Van Saun, certify that:



1. I have reviewed this annual report on Form 10-K of The Bank of New York Company, Inc. (the registrant);



2. Based on my knowledge, this annual report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
annual report;



3. Based on my knowledge, the
financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
this annual report;



4. The registrants
other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a) Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this annual report is being prepared;



(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of
the end of the period covered by this annual report based on such evaluation; and



(c) Disclosed in this annual report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over
financial reporting; and



5. The
registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of
directors (or persons performing the equivalent functions):



(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and



(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.



Date: March 9, 2004



|                                         
|-----------------------------------------
|                                         
|/s/    BRUCE W. VAN SAUN                 
|                                         
|Bruce W. Van Saun Chief Financial Officer



-1-
EXHIBIT 31.2
                  CERTIFICATION PURSUANT TO 18 U.S.C. ss. 1350,
      AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Gregory Adams, certify that:

1. I have reviewed  this  quarterly  report on Form 10 QSB of Online  Originals,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this quarterly report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. I am responsible for  establishing  and maintaining  disclosure  controls and
procedures  (as  defined  in  Exchange  Act Rules  13a-14  and  15d-14)  for the
registrant and I have:

      a)  designed  such  disclosure  controls  and  procedures  to ensure  that
          material  information  relating  to  the  registrant,   including  its
          consolidated subsidiaries,  is made known to us by others within those
          entities,  particularly  during  the  period in which  this  quarterly
          report is being prepared;

      b)  evaluated the  effectiveness of the registrant's  disclosure  controls
          and procedures as of a date within 90 days prior to the filing date of
          this quarterly report (the "Evaluation Date"); and

      c)  presented in this report our conclusions  about the  effectiveness  of
          the disclosure  controls and procedures  based on our evaluation as of
          the Evaluation Date;

5. I have disclosed,  based on our most recent  evaluation,  to the registrant's
auditors and the audit committee of registrant's  board of directors (or persons
performing the equivalent function):

      a)  all  significant  deficiencies  in the design or operation of internal
          controls  which could  adversely  affect the  registrant's  ability to
          record,  process,   summarize  and  report  financial  data  and  have
          identified for the  registrant's  auditors any material  weaknesses in
          internal controls; and

      b)  any fraud, whether or not material,  that involves management or other
          employees who have a  significant  role in the  registrant's  internal
          controls; and

6. I have indicated in this report whether or not there were significant changes
in  internal  controls  or in other  factors  that  could  significantly  affect
internal  controls  subsequent  to the  date  of  our  most  recent  evaluation,
including any  corrective  actions with regard to significant  deficiencies  and
material weaknesses.

Date:    July 16, 2007


By:      /s/ Gregory Adams
         -------------------------------
         Gregory Adams
         Chief Financial Officer
H. Res. 329 

In the House of Representatives, U. S., 

May 1, 2019. 

Resolved, That at any time after adoption of this resolution the Speaker may, pursuant to clause 2(b) of rule XVIII, 

declare the House resolved into the Committee of the Whole 

House on the state of the Union for consideration of the bill 

(H.R. 9) to direct the President to develop a plan for the 

United States to meet its nationally determined contribution 

under the Paris Agreement, and for other purposes. The first 

reading of the bill shall be dispensed with. All points of order 

against consideration of the bill are waived. General debate 

shall be confined to the bill and shall not exceed 90 minutes, 

with 60 minutes equally divided and controlled by the chair 

and ranking minority member of the Committee on Foreign 

Affairs and 30 minutes equally divided and controlled by the 

chair and ranking minority member of the Committee on Energy and Commerce. After general debate the bill shall be 

considered for amendment under the five-minute rule. The 

bill shall be considered as read. All points of order against 

provisions in the bill are waived. No amendment to the bill 
2 

•HRES 329 EH 

shall be in order except those printed in the report of the 

Committee on Rules accompanying this resolution. Each such 

amendment may be offered only in the order printed in the 

report, may be offered only by a Member designated in the 

report, shall be considered as read, shall be debatable for the 

time specified in the report equally divided and controlled by 

the proponent and an opponent, shall not be subject to 

amendment, and shall not be subject to a demand for division 

of the question in the House or in the Committee of the 

Whole. All points of order against such amendments are 

waived. At the conclusion of consideration of the bill for 

amendment the Committee shall rise and report the bill to 

the House with such amendments as may have been adopted. 

The previous question shall be considered as ordered on the 

bill and amendments thereto to final passage without intervening motion except one motion to recommit with or without 

instructions. 

Attest: 

Clerk.